Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hunzelmann, Nicolas
DupiMorph, NCT04200755 / 2019-002036-90: Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma	Completed	2	45	Europe	Dupilumab 300Mg Solution for Injection, Dupixent, Placebo	University of Cologne, Sanofi Aventis	Localized Scleroderma	11/23	11/23